The 2023 Michelson Prizes are looking for research aimed at tackling the current roadblocks that exist in human vaccine development and expanding the limited understanding of key immune processes that are fundamental to successful vaccine and immunotherapy development. Reviewers will be looking for research that is highly innovative and impactful, with the potential to be applied across many diseases.
While the Michelson Prizes are focused on research in the fields of immunology, vaccine and immunotherapy discovery, applicants from the full spectrum of related disciplines, including clinical research, biochemistry, molecular biology, protein engineering, computer science, artificial intelligence/machine learning, biophysics, nanotechnology, etc., are encouraged to apply.
Applications are encouraged from the full spectrum of scientific disciplines related to immunology, vaccine, and immunotherapy research, including but not limited to: